ArticleFrontiers in neurology2025
The efficacy of high-frequency repetitive transcranial magnetic stimulation on upper extremity function in intracerebral hemorrhage: a real-world retrospective cohort study.
Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Repetitive transcranial magnetic stimulation (rTMS) has been applied to improve upper limb motor recovery following stroke. However, most existing evidence is derived from ischemic stroke populations, with limited studies specifically evaluating its efficacy in intracerebral hemorrhage (ICH). Objective: To explore the efficacy of rTMS on upper extremity function in a cohort exclusively composed of ICH patients, providing real-world evidence on its application in this underrepresented population. Methods: A retrospective cohort study was conducted including 394 patients diagnosed with ICH who were admitted to the Department of Rehabilitation Medicine at Bethune Hospital of Shanxi between January 2020 and June 2023. Patients were divided into two groups: conventional rehabilitation therapy alone or in combination with high-frequency rTMS (HF-rTMS). The primary endpoint was the proportion of patients achieving a clinically meaningful improvement (≥9 points) in the Fugl-Meyer Upper Extremity (FM-UE) Scale. Results: HF-rTMS treatment was significantly associated with an increased likelihood of achieving the primary endpoint (OR = 3.19, 95% CI 1.81-5.65, Conclusion: This large-scale real-world study exclusively focused on ICH provides critical evidence supporting the efficacy of HF-rTMS in subacute ICH rehabilitation. Given the paucity of dedicated research on ICH, these findings offer valuable insights into personalized neuromodulatory treatment strategies for this understudied population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.